DE60137960D1 - Pharmazeutische zusammensetzungen mit corticosteroiden und antiinfektiva - Google Patents

Pharmazeutische zusammensetzungen mit corticosteroiden und antiinfektiva

Info

Publication number
DE60137960D1
DE60137960D1 DE60137960T DE60137960T DE60137960D1 DE 60137960 D1 DE60137960 D1 DE 60137960D1 DE 60137960 T DE60137960 T DE 60137960T DE 60137960 T DE60137960 T DE 60137960T DE 60137960 D1 DE60137960 D1 DE 60137960D1
Authority
DE
Germany
Prior art keywords
pharmaceutically acceptable
agent
corticosteroides
infectives
inflammatory agent
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60137960T
Other languages
English (en)
Inventor
Mohan A Chandavarkar
Nandan Mohan Chandavarkar
Mainde Chandrashekhar
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
CHANDAVARKAR NANDAN M
Original Assignee
CHANDAVARKAR NANDAN M
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by CHANDAVARKAR NANDAN M filed Critical CHANDAVARKAR NANDAN M
Application granted granted Critical
Publication of DE60137960D1 publication Critical patent/DE60137960D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/40—Cyclodextrins; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Ophthalmology & Optometry (AREA)
  • Inorganic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Steroid Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DE60137960T 2000-11-15 2001-11-12 Pharmazeutische zusammensetzungen mit corticosteroiden und antiinfektiva Expired - Lifetime DE60137960D1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
IN1018MU2000 2000-11-15
IN1077MU2001 2001-11-09
PCT/IN2001/000199 WO2002039993A2 (en) 2000-11-15 2001-11-12 Pharmaceutival preparations comprising corticosteroids and antiinfective agents

Publications (1)

Publication Number Publication Date
DE60137960D1 true DE60137960D1 (de) 2009-04-23

Family

ID=26324912

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60137960T Expired - Lifetime DE60137960D1 (de) 2000-11-15 2001-11-12 Pharmazeutische zusammensetzungen mit corticosteroiden und antiinfektiva

Country Status (9)

Country Link
US (2) US20040077562A1 (de)
EP (1) EP1337237B1 (de)
AT (1) ATE424808T1 (de)
AU (2) AU2002216357B2 (de)
BR (1) BR0115415A (de)
CA (1) CA2428189A1 (de)
DE (1) DE60137960D1 (de)
MX (1) MXPA03004241A (de)
WO (1) WO2002039993A2 (de)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004069280A1 (en) * 2003-02-06 2004-08-19 Cipla Ltd Pharmaceutical inclusion complexes containing a steroid and optionally an antibacterial agent
EP1596823A2 (de) * 2003-02-21 2005-11-23 Sun Pharmaceuticals Industries Ltd. Stabile ophthalmische zusammensetzung
WO2004103373A1 (ja) * 2003-05-23 2004-12-02 Santen Pharmaceutical Co.,Ltd. キノロン系抗菌化合物を含有する点眼液
US20060141049A1 (en) * 2003-11-12 2006-06-29 Allergan, Inc. Triamcinolone compositions for intravitreal administration to treat ocular conditions
US20050101582A1 (en) 2003-11-12 2005-05-12 Allergan, Inc. Compositions and methods for treating a posterior segment of an eye
US20070224278A1 (en) * 2003-11-12 2007-09-27 Lyons Robert T Low immunogenicity corticosteroid compositions
US20070020299A1 (en) 2003-12-31 2007-01-25 Pipkin James D Inhalant formulation containing sulfoalkyl ether cyclodextrin and corticosteroid
EP1706095B1 (de) 2004-01-20 2008-12-24 Allergan, Inc. Zusammensetzungen für die lokalisierte therapie des auges, vorzugsweise enthaltend triamcinolon-acetonid und hyaluronsäure
US7892483B2 (en) 2004-03-12 2011-02-22 Cipla Limited Sterilization process
US8119154B2 (en) * 2004-04-30 2012-02-21 Allergan, Inc. Sustained release intraocular implants and related methods
US8147865B2 (en) 2004-04-30 2012-04-03 Allergan, Inc. Steroid-containing sustained release intraocular implants and related methods
US8748402B2 (en) 2004-06-07 2014-06-10 Bausch & Lomb Pharma Holdings Corp. Ophthalmic formulations and uses thereof
US8372814B2 (en) 2004-06-07 2013-02-12 Ista Pharmaceuticals, Inc. Ophthalmic formulations and uses thereof
US20050287212A1 (en) * 2004-06-28 2005-12-29 Liang-Chang Dong Oral delivery system comprising a drug/polymer complex
AU2005271700B2 (en) * 2004-07-12 2010-11-11 Allergan, Inc. Opthalmic compositions and methods for treating ophthalmic conditions
WO2006043965A1 (en) * 2004-10-14 2006-04-27 Allergan, Inc. Therapeutic ophthalmic compositions containing retinal friendly excipients and related methods
US8668676B2 (en) * 2006-06-19 2014-03-11 Allergan, Inc. Apparatus and methods for implanting particulate ocular implants
WO2008002117A1 (es) * 2006-06-27 2008-01-03 Jimenez Bayardo, Arturo Solución oftálmica de ciprofloxacina y dexametasona
US9039761B2 (en) 2006-08-04 2015-05-26 Allergan, Inc. Ocular implant delivery assemblies with distal caps
KR20090111328A (ko) * 2007-01-17 2009-10-26 데비렉스 아게 사이클로덱스트린 제형
WO2008130211A1 (es) * 2007-04-20 2008-10-30 Serral, S.A. De C.V. Solución dinámica, estequiométrica de soporte y de equilibrio inducido
US8545554B2 (en) * 2009-01-16 2013-10-01 Allergan, Inc. Intraocular injector
MD3548091T2 (ro) * 2016-11-29 2022-03-31 Oculis SA Prepararea complexelor solide de ciclodextrină pentru livrarea ingredientelor farmaceutice active oftalmice
US20230233572A1 (en) 2020-06-11 2023-07-27 Sentiss Pharma Private Limited Ophthalmic compositions comprising a combination of fluoroquinolone antibacterial agent and an anti-inflammatory agent

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU4201189A (en) * 1988-08-26 1990-03-23 Alcon Laboratories, Inc. Combination of quinolone antibiotics and steroids for topical ophthalmic use
US5374432A (en) * 1989-07-28 1994-12-20 The Trustees Of Columbia University Of The City Of New York Topical anti-infective ointment containing silver or silver salts and antibiotics
US5318780A (en) * 1991-10-30 1994-06-07 Mediventures Inc. Medical uses of in situ formed gels
US5472954A (en) * 1992-07-14 1995-12-05 Cyclops H.F. Cyclodextrin complexation
US5540930A (en) * 1993-10-25 1996-07-30 Pharmos Corporation Suspension of loteprednol etabonate for ear, eye, or nose treatment
US5516808A (en) * 1994-10-27 1996-05-14 Sawaya; Assad S. Topical cellulose pharmaceutical formulation
AU776609B2 (en) * 1999-09-24 2004-09-16 Novartis Ag Topical suspension formulations containing ciprofloxacin and dexamethasone
US6824804B2 (en) * 2001-09-27 2004-11-30 Broyles Properties, Ltd. Pecan processing method and system

Also Published As

Publication number Publication date
EP1337237B1 (de) 2009-03-11
AU1635702A (en) 2002-05-27
ATE424808T1 (de) 2009-03-15
US20040077562A1 (en) 2004-04-22
AU2002216357B2 (en) 2006-08-17
WO2002039993A3 (en) 2003-02-27
BR0115415A (pt) 2003-09-09
WO2002039993A2 (en) 2002-05-23
CA2428189A1 (en) 2002-05-23
EP1337237A2 (de) 2003-08-27
US20070248565A1 (en) 2007-10-25
MXPA03004241A (es) 2004-12-03

Similar Documents

Publication Publication Date Title
DE60137960D1 (de) Pharmazeutische zusammensetzungen mit corticosteroiden und antiinfektiva
CY1112499T1 (el) Φαρμακευτικες συνθεσεις ενος νευροδραστικου στεροειδους και χρησεις αυτων
AU2002243387A1 (en) Pharmaceutical dosage form for oral administration of low molecular weight heparin
CY1118206T1 (el) Φαρμακευτικη συνθεση για δερματικη χρηση για να θεραπευεται ψωριαση που περιλαμβανει καλσιποτριολη και βηταμεθαζονη
ATE513541T1 (de) Pharmazeutische zusammensetzungen zur oralen verabreichung von calcitonin
DK1061915T3 (da) Farmaceutiske formuleringer af taxaner
DK0991407T3 (da) Stabilisering af syresensitive benzimidazoler med amino/cyclodextrin-kombinationer
CY1115289T1 (el) Μεθοδοι αγωγης εναντι ασθενειας που σχετιζεται με φλεγμονη
AU2002239282A1 (en) Pharmaceutical formulations comprising paclitaxel, derivatives, and pharmaceutically acceptable salts thereof
TR200201082T2 (tr) Glikopriranoziloksipirazol türevleri
EE200400033A (et) Vähelahustuvaid ja/või happetundlikke ravimeid janeutraliseeritud happelisi polümeere sisaldavad farmatseutilised kompositsioonid
TR200102226T2 (tr) Formoterol ve bir tiotropium tuzunun kombinasyonları
ATE235895T1 (de) Arzneistoff-abgabesystem enthaltend eine festgepackte, feste arzneistoffbasis
PT1289576E (pt) Combinacoes de medicamentos uteis para a prevencao da restenose
CY1105795T1 (el) Σκευασματα για βελτιωση της βιοδιαθεσιμοτητας χορηγουμενων απο το στομα φαρμακων
CY1105953T1 (el) Συνθεσεις για απελευθερωση συνδυασμων φαρμακων
CY1111698T1 (el) Συνδυασμος που περιλαμβανει εναν ανταγωνιστη υποδοχεα ατ1 και εναν ενισχυτη εκκρισης ινσουλινης ή εναν ευαισθητοποιητη ινσουλινης
BRPI0008228B8 (pt) composição farmacêutica contendo n-benzoil estaurosporina e agentes solubilizantes
TR199900336T2 (xx) EAA antagonistleri olarak tetrahidrokinolin t�revleri.
DE60313359D1 (de) Fenofibratsäure enthaltende pharmazeutische zusammensetzung und deren physiologisch verträgliche salze und derivate
HRP20030050B1 (en) Sustained-release preparations of quinolone antibiotics and method for preparation thereof
DK1957037T3 (da) Farmaceutisk præparat til nasal anvendelse af fentanyl
RS50348B (sr) Farmaceutski oblik dronedarona za parenteralnu upotrebu
PT1150704E (pt) Melagatran para o tratamento da inflamacao
NO20031410L (no) Anvendelse av distamycinderivater for fremstilling av medikamenter

Legal Events

Date Code Title Description
8364 No opposition during term of opposition